COVID-19 Diagnostics Market to Hit USD 11.40 Billion by 2027; Growing Urgency for Efficient Testing of Symptomatic COVID Patients to Boost the Market: Fortune Business Insights™

Ads

You May Also Like

Aptevo Therapeutics Augments Leadership Team

Appoints Former GlaxoSmithKline Executive Randy Maddux Senior Vice President, Operations Jane Gross, Ph.D., Promoted to ...

Immunomedics Announces New Patent Covering the Use of Antibody-SN-38 Conjugates Combination

MORRIS PLAINS, N.J., Jan. 05, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU) today announced ...